Helicobacter pylori infection is associated with elevated galactose-deficient IgA1 in IgA nephropathy

References

• Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med. 2013;368(25):2402–2414.
   PubMed Web of Science ®Google Scholar
• Perse M, Veceric-Haler Z. The role of IgA in the pathogenesis of IgA nephropathy. Int J Mol Sci. 2019;20(24):6199.
   PubMed Web of Science ®Google Scholar
• Zhang YM, Zhang H. Insights into the role of mucosal immunity in IgA nephropathy. Clin J Am Soc Nephrol. 2018;13(10):1584–1586.
   PubMed Web of Science ®Google Scholar
• Zhu TT, Wang L, Wang HL, et al. Helicobacter pylori participates in the pathogenesis of IgA nephropathy. Ren Fail. 2016;38(9):1398–1404.
   PubMed Web of Science ®Google Scholar
• Kusano K, Inokuchi A, Fujimoto K, et al. Coccoid Helicobacter pylori exists in the palatine tonsils of patients with IgA nephropathy. J Gastroenterol. 2010;45(4):406–412.
   PubMed Web of Science ®Google Scholar
• Niknam R, Barfei M, Mahmoudi L. Helicobacter pylori, endoscopic, and histologic features among kidney transplant candidates in southern Iran. IDR. 2019;12(1):3687–3693.
   Google Scholar
• Pan W, Zhang H, Wang L, et al. Association between Helicobacter pylori infection and kidney damage in patients with peptic ulcer. Ren Fail. 2019;41(1):1028–1034.
   PubMed Web of Science ®Google Scholar
• Shin SP, Bang CS, Lee JJ, et al. Helicobacter pylori infection in patients with chronic kidney disease: a systematic review and meta-analysis. Gut Liver. 2019;13(6):628–641.
   PubMed Web of Science ®Google Scholar
• Barratt J, Bailey EM, Buck KS, et al. Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathy. Am J Kidney Dis. 1999;33(6):1049–1057.
   PubMed Web of Science ®Google Scholar
• Chmiela M, Kupcinskas J. Review: pathogenesis of Helicobacter pylori infection. Helicobacter. 2019;24(Suppl 1):e12638.
   PubMed Web of Science ®Google Scholar
• Kusano K, Tokunaga O, Ando T, et al. Helicobacter pylori in the palatine tonsils of patients with IgA nephropathy compared with those of patients with recurrent pharyngotonsillitis. Hum Pathol. 2007;38(12):1788–1797.
   PubMed Web of Science ®Google Scholar
• Wang L, Tan RZ, Chen Y, et al. CagA promotes proliferation and secretion of extracellular matrix by inhibiting signaling pathway of apoptosis in rat glomerular mesangial cells. Ren Fail. 2016;38(3):458–464.
   PubMed Web of Science ®Google Scholar
• Galmiche A, Rassow J, Doye A, et al. The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. Embo J. 2000;19(23):6361–6370.
   PubMed Web of Science ®Google Scholar
• Molinari M, Salio M, Galli C, et al. Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J Exp Med. 1998;187(1):135–140.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al.; for the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
   PubMed Web of Science ®Google Scholar
• Doolan PD, Alpen EL, Theil GB. A clinical appraisal of the plasma concentration and endogenous clearance of creatinine. Am J Med. 1962;32:65–79.
   PubMed Web of Science ®Google Scholar
• Cattran DC, Coppo R, Cook HT, et al.; Working Group of the International Ig ANN. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76(5):534–545.
   PubMed Web of Science ®Google Scholar
• Zhao N, Hou P, Lv J, et al. The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression. Kidney Int. 2012;82(7):790–796.
   PubMed Web of Science ®Google Scholar
• Zhang K, Li Q, Zhang Y, et al. Clinical significance of galactose-deficient IgA1 by KM55 in patients with IgA nephropathy. Kidney Blood Press Res. 2019;44(5):1196–1206.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Yasutake J, Makita Y, et al. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. Kidney Int. 2018;93(3):700–705.
   PubMed Web of Science ®Google Scholar
• Kiryluk K, Novak J, Gharavi AG. Pathogenesis of immunoglobulin A nephropathy: recent insight from genetic studies. Annu Rev Med. 2013;64(1):339–356.
   PubMedGoogle Scholar
• Novak J, Moldoveanu Z, Julian BA, et al. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system. Adv Otorhinolaryngol. 2011;72(1):60–63.
   PubMedGoogle Scholar
• Bravo D, Hoare A, Soto C, et al. Helicobacter pylori in human health and disease: mechanisms for local gastric and systemic effects. World J Gastroenterol. 2018;24(28):3071–3089.
   PubMed Web of Science ®Google Scholar
• Robinson K. Helicobacter pylori-mediated protection against extra-gastric immune and inflammatory disorders: the evidence and controversies. Diseases. 2015;3(2):34–55.
   PubMedGoogle Scholar
• Kanbay M, Kasapoglu B, Akcay A. An occult risk factor for proteinuria: Helicobacter pylori infection. Med Hypotheses. 2007;69(3):709–710.
   PubMed Web of Science ®Google Scholar
• Migneco A, Ojetti V, Specchia L, et al. Eradication of Helicobacter pylori infection improves blood pressure values in patients affected by hypertension. Helicobacter. 2003;8(6):585–589.
   PubMed Web of Science ®Google Scholar
• Caliskan B, Yazici H, Caliskan Y, et al. The effects of Helicobacter pylori eradication on proteinuria in patients with primary glomerulonephritis. Int J Nephrol. 2014;2014(1):180690.
   PubMedGoogle Scholar
• Smith AC, Molyneux K, Feehally J, et al. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. J Am Soc Nephrol. 2006;17(12):3520–3528.
   PubMed Web of Science ®Google Scholar
• Yang M, Li FG, Xie XS, et al. CagA, a major virulence factor of Helicobacter pylori, promotes the production and underglycosylation of IgA1 in DAKIKI cells. Biochem Biophys Res Commun. 2014;444(2):276–281.
   PubMed Web of Science ®Google Scholar
• Novak J, Barratt J, Julian BA, et al. Aberrant glycosylation of the IgA1 molecule in IgA nephropathy. Semin Nephrol. 2018;38(5):461–476.
   PubMed Web of Science ®Google Scholar
• Somily AM, Morshed MG. An update of laboratory diagnosis of Helicobacter pylori in the Kingdom of Saudi Arabia. J Infect Dev Ctries. 2015;9(8):806–814.
   PubMed Web of Science ®Google Scholar
• Chey WD, Wong BC. Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102(8):1808–1825.
   PubMed Web of Science ®Google Scholar
• Bagchi S, Lingaiah R, Mani K, et al. Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: a case control study. PLoS One. 2019;14(3):e0214256.
   PubMed Web of Science ®Google Scholar
• Hastings MC, Afshan S, Sanders JT, et al. Serum galactose-deficient IgA1 level is not associated with proteinuria in children with IgA nephropathy. Int J Nephrol. 2012;2012:315467.
   PubMedGoogle Scholar